Journal of Clinical Oncology 临床肿瘤· Youngwoo Cho·· 2026-10-08AI 评分45
JCO 评论以 zolbetuximab 为例讨论关键临床试验的受试人群代表性
Importance of Inclusion of Representative Populations in Pivotal Clinical Trials: Zolbetuximab as an Example
AI 导读
《Journal of Clinical Oncology》刊登一篇评论,以 zolbetuximab 为案例讨论关键临床试验纳入代表性受试人群的重要性。文章载于第 44 卷第 29 期,页码 2773-2776,目前仅有摘要信息。
来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org